Summit Creek Advisors’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$323K	Buy	1,290 +324	+34%	+$80.6K	0.07%	57
2025 Q4	$266K	Hold	966	–	–	0.04%	62
2025 Q3	$253K	Sell	966 -66	-6%	-$16K	0.04%	67
2025 Q2	$226K	Hold	1,032	–	–	0.03%	68
2025 Q1	$231K	Buy	1,032 +5	+0.5%	+$1.38K	0.03%	66
2024 Q4	$336K	Hold	1,027	–	–	0.04%	62
2024 Q3	$308K	Sell	1,027 -66	-6%	-$20.2K	0.04%	67
2024 Q2	$360K	Hold	1,093	–	–	0.05%	60
2024 Q1	$433K	Buy	1,093 +14	+1%	+$5.18K	0.05%	59
2023 Q4	$380K	Hold	1,079	–	–	0.05%	58
2023 Q3	$405K	Hold	1,079	–	–	0.06%	58
2023 Q2	$413K	Buy	1,079 +1	+0.1%	+$357	0.05%	60
2023 Q1	$373K	Hold	1,078	–	–	0.05%	61
2022 Q4	$254K	Buy	1,078 +9	+0.8%	+$2.13K	0.03%	68
2022 Q3	$263K	Sell	1,069 -767	-42%	-$234K	0.04%	66
2022 Q2	$555K	Buy	1,836 +28	+2%	+$9.11K	0.07%	64
2022 Q1	$743K	Buy	1,808 +10	+0.6%	+$3.92K	0.08%	64
2021 Q4	$843K	Buy	1,798 +4	+0.2%	+$1.72K	0.08%	64
2021 Q3	$762K	Buy	1,794 +450	+33%	+$190K	0.08%	65
2021 Q2	$483K	Hold	1,344	–	–	0.06%	62
2021 Q1	$379K	Buy	1,344 +374	+39%	+$107K	0.05%	63
2020 Q4	$275K	Sell	970 -2,940	-75%	-$825K	0.04%	64
2020 Q3	$1.07M	Hold	3,910	–	–	0.16%	61
2020 Q2	$888K	Hold	3,910	–	–	0.13%	62
2020 Q1	$595K	Hold	3,910	–	–	0.12%	63
2019 Q4	$588K	Hold	3,910	–	–	0.09%	62
2019 Q3	$555K	Buy	+3,910	New	+$538K	0.09%	62